Large-scale testing (Phase 3)Study completedNCT03726879
What this trial is testing
Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer
Who this might be right for
Breast Cancer
Hoffmann-La Roche 454